PAREXEL

Theorem Clinical Research names Joseph Sgherza head of infectious diseases

Tuesday, October 1, 2013 09:44 AM

Global CRO Theorem Clinical Research has named Joseph Sgherza vice president of biopharmaceutical development for its infectious disease franchise. Sgherza has 24 years in the pharmaceutical, biotech and CRO industries.

More... »

Parexel launches China Trials Solution

Monday, September 30, 2013 02:40 PM

Global CRO Parexel International has launched Parexel Dĭng Huī, China Trials Solution. The offering combines advanced technology and international SOPs (Standard Operating Procedures) with local experience and resources to deliver cost-effective services that meet global quality standards. Parexel Dĭng Huī will support clients through locally delivered, streamlined services that support single-country registration trials and are tailored to meet Chinese NDA submission requirements.

More... »

Rutgers, Parexel collaborate to optimize clinical trial services

Monday, July 8, 2013 01:05 PM

Rutgers New Jersey Medical School (NJMS) has been selected by Parexel International, a global biopharmaceutical services provider, as a Key Alliance Site. This will give NJMS ongoing, long-term access to trial opportunities through Parexel’s client base.

More... »

Parexel launches functional services unit

Monday, June 24, 2013 03:39 PM

Parexel International has announced the launch of Parexel Functional Services within the company's Clinical Research Services business segment.

More... »

Parexel names Ingo Bank senior vice president, CFO

Monday, June 17, 2013 02:03 PM

Global CRO Parexel International has named Ingo Bank senior vice president, and he will become chief financial officer September after fiscal year-end audited financial statements are filed. 

More... »

Parexel opens Shenyang office

Tuesday, May 28, 2013 02:23 PM

Global CRO Parexel International has opened a new office in Shenyang, China, to support growing client demand for a broad range of clinical development capabilities throughout the Asia Pacific region. The office expands Parexel's presence in China, which includes locations in Beijing, Chengdu, Guangzhou, Shanghai and Hong Kong. PAREXEL now has 22 offices in the Asia Pacific region, including in Australia, Japan, India, Indonesia, Malaysia, the Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.

More... »

Parexel International acquires Heron Group

Wednesday, May 1, 2013 09:57 AM

Parexel International, a global CRO, has acquired all outstanding equity securities of the Heron Group, a Luton, U.K.-based life sciences consultancy that provides evidence-based commercialization services to support biopharmaceutical companies throughout the lifecycle of their products. 

More... »

PAREXEL honored with 2013 "Partnership Pioneers of the Year" Award

Monday, April 29, 2013 11:09 AM

PAREXEL International, a global biopharmaceutical services provider, has been named a recipient of the 2013 "Partnership Pioneers of the Year" award in recognition of its innovative strategic partnership with Pfizer and ICON.

More... »

Parexel CEO Rickenbach to receive MassBio’s Henri Termeer Innovative Leadership Award

Monday, March 11, 2013 02:35 PM

Josef von Rickenbach, chairman and CEO of Parexel International, a global bio/pharmaceutical services organization, will be honored for his commitment and contributions to the biotechnology industry, by the Massachusetts Biotechnology Council (MassBio), a not-for-profit organization that represents and provides services and support for the Massachusetts biotechnology industry.

More... »

The CenterWatch Monthly, March 2013

Friday, March 1, 2013 08:00 AM

Sites rate the best sponsors 2013

More... »